- Xiaona Jing
- Director Global CMC & Pharmaceutical Development
- NBE-therapeutics, Switzerland
Dr. Xiaona Jing is currently heading the CMC and Pharmaceutical Development of NBE-Therapeutics, a Basel based start-up biotech focusing on innovative next-generation ADC for cancer patients. Previously she has been working for Roche and Genmab, with focus on developing innovative oncology products such as antibody and ADC.
She is experienced in establishing global supply chain for complicated products through outsourcing management of contract organizations. Currently she is pioneering the transformation of the NBE ADC technology to GMP manufacturing platforms through 100% CMC outsourcing involving multiple CMOs around the world.